Disclosure Of Fair Value Measurement [Text Block]

Sopharma AD - Filing #6022425

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
1 514 162 BGN
1 253 978 BGN
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
760 536 BGN
537 344 BGN
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
753 626 BGN
395 897 BGN
1 857 BGN
29 328 BGN
15 294 BGN
172 591 BGN
1 154 BGN
57 452 BGN
738 332 BGN
506,000 BGN
196 759 BGN
68 628 BGN
716 634 BGN
35 263 BGN
12 488 BGN
11 976 BGN
509 869 BGN
52 203 BGN
134 798 BGN
4 745 BGN
704 658 BGN
560,000 BGN
50 284 BGN
66 201 BGN
36 788 BGN
444 634 BGN
658 868 BGN
1 644 BGN
12 512 BGN
646 975 BGN
11 893 BGN
682,000 BGN
134 798 BGN
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.